VIVUS Reports First Quarter 2013 Financial Results
08 mai 2013 07h30 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
VIVUS Announces Richard Fante, Former President U.S. and CEO North America, AstraZeneca, to Serve as Senior Advisor
07 mai 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 7, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the Company) today announced that Richard Fante, former president U.S., CEO North America and regional vice president...
VIVUS Announces Date of First Quarter 2013 Financial Results and Conference Call
01 mai 2013 07h05 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2013 before the NASDAQ...
New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity
01 mai 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- A new comprehensive treatment algorithm for diabetes from the American Association of Clinical Endocrinologists (AACE) is the first to recommend...
VIVUS Appoints Robert N. Wilson to Board of Directors
30 avr. 2013 07h00 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., April 30, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the appointment of Robert N. Wilson, chairman of Mevion Medical Systems and former vice chairman of...
VIVUS Announces Positive Recommendation From CHMP Supporting Avanafil Approval in Europe
26 avr. 2013 09h25 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., April 26, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)...
VIVUS to Present at Four Upcoming Investor Conferences
22 avr. 2013 08h30 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at four investment conferences during the...
VIVUS Announces $110 Million Synthetic Capped Royalty Financing
26 mars 2013 06h30 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., March 26, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it has entered into a $110 million non-equity financing with an investment fund managed by...
VIVUS Confirms Receipt of Notice of Nomination From First Manhattan Co.
08 mars 2013 15h15 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., March 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
VIVUS to Present at Three Investor Conferences in March 2013
04 mars 2013 06h45 HE
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., March 4, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at three investment conferences during the...